Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 Reduction

MLA

Takashi Yoshioka, et al. “Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 Reduction.” Life, vol. 11, Aug. 2021, p. 885. EBSCOhost, https://doi.org/10.3390/life11090885.

APA

Takashi Yoshioka, Keita Togashi, Chifumi Kitanaka, Asuka Sugai, Shizuka Seino, Masashi Okada, Masahiro Yamamoto, Tomomi Sanomachi, & Shuhei Suzuki. (2021). Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 Reduction. Life, 11, 885. https://doi.org/10.3390/life11090885

Chicago

Takashi Yoshioka, Keita Togashi, Chifumi Kitanaka, Asuka Sugai, Shizuka Seino, Masashi Okada, Masahiro Yamamoto, Tomomi Sanomachi, and Shuhei Suzuki. 2021. “Dexamethasone Sensitizes Cancer Stem Cells to Gemcitabine and 5-Fluorouracil by Increasing Reactive Oxygen Species Production through NRF2 Reduction.” Life 11 (August): 885. doi:10.3390/life11090885.